Literature DB >> 22565000

Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?

Matthew Martin1, Richard Marais.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22565000     DOI： 10.1200/JCO.2012.42.1677

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  23 in total

1.  Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho.

Authors:  Reeti Behera; Amanpreet Kaur; Marie R Webster; Suyeon Kim; Abibatou Ndoye; Curtis H Kugel; Gretchen M Alicea; Joshua Wang; Kanad Ghosh; Phil Cheng; Sofia Lisanti; Katie Marchbank; Vanessa Dang; Mitchell Levesque; Reinhard Dummer; Xiaowei Xu; Meenhard Herlyn; Andrew E Aplin; Alexander Roesch; Cecilia Caino; Dario C Altieri; Ashani T Weeraratna
Journal:  Clin Cancer Res       Date:  2017-02-23       Impact factor: 12.531

Review 2.  Effects of sulfonylureas on tumor growth: a review of the literature.

Authors:  Giulia Pasello; Loredana Urso; Pierfranco Conte; Adolfo Favaretto
Journal:  Oncologist       Date:  2013-09-16

3.  Direct effects of phenformin on metabolism/bioenergetics and viability of SH-SY5Y neuroblastoma cells.

Authors:  Fintan Geoghegan; Naomi Chadderton; G Jane Farrar; Daniela M Zisterer; Richard K Porter
Journal:  Oncol Lett       Date:  2017-09-14       Impact factor: 2.967

4.  Metformin inhibits salivary adenocarcinoma growth through cell cycle arrest and apoptosis.

Authors:  Yuqi Guo; Tao Yu; Jian Yang; Tianqing Zhang; Yang Zhou; Fan He; Zoya Kurago; David Myssiorek; Yingjie Wu; Peng Lee; Xin Li
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

Review 5.  Molecular pathophysiology of hepatic glucose production.

Authors:  Kfir Sharabi; Clint D J Tavares; Amy K Rines; Pere Puigserver
Journal:  Mol Aspects Med       Date:  2015-11-05

6.  Diabetes mellitus and ovarian cancer: more complex than just increasing risk.

Authors:  Monjri M Shah; Britt K Erickson; Tasnia Matin; Gerald McGwin; Jovana Y Martin; Laura Becca Daily; Daniel Pasko; Christen W Haygood; Janelle M Fauci; Charles A Leath
Journal:  Gynecol Oncol       Date:  2014-09-16       Impact factor: 5.482

Review 7.  Repurposing metformin for the treatment of gastrointestinal cancer.

Authors:  Ademar Dantas Cunha Júnior; Arinilda Campos Bragagnoli; Felipe Osório Costa; José Barreto Campello Carvalheira
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

8.  Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients.

Authors:  Susie Bae; Hui-Li Wong; Jeanne Tie; Jayesh Desai; Kathryn Field; Suzanne Kosmider; Spiros Fourlanos; Ian Jones; Iain Skinner; Peter Gibbs
Journal:  J Cancer Epidemiol       Date:  2015-05-05

Review 9.  Use of noninsulin anti diabetics for prevention and treatment of cancer- narrative review article.

Authors:  Sadaf Raana; Aqeel Javeed
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

10.  Diabetes and risk of cancer.

Authors:  Samy L Habib; Maciej Rojna
Journal:  ISRN Oncol       Date:  2013-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.